Metvix PDT in Participant With "High Risk" Basal Cell Carcinoma

Clinical trial NCT00473343 · COMPLETED

Trial details

NCT number: NCT00473343
Sponsor: Galderma R&D
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Basal Cell Carcinoma

Start date: 2000-09-01
Primary completion: 2006-06-01
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.